HLA-C and neoplasm: Genetic variants, including loss of function mutations in genes related to MHC proteins’ expression (e.g., TAP1, TAP2, HLA, CREBBP, CIITA), lead to one of the major mechanisms of tumor immune surveillance evasion described to date [17, 25, 26].